Company

SynOx Therapeutics

Biotechnology Research Ie 26 employees

Employees: 26
Contacts: 4
Emails: 4
Phones: 1

synoxtherapeutics.com LinkedIn Crunchbase

SynOx Therapeutics Overview

Headquarters: Ie
Website: synoxtherapeutics.com
Industry: Biotechnology Research
Employees: 26
Founded: 2020
Funding: 92.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About SynOx Therapeutics

SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.

SynOx Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 1; 25.0% coverage

SynOx Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Christine (Christy) Obercian, Ms, PMP	Clinical Research Executive Leadership	West Chester, Pennsylvania, United States	Email Phone
Elyse Seltzer, Md	Chief Medical Officer Synox Therapeutics	Philadelphia, Pennsylvania, United States	Email
Robert Francomano	Chief Commercial Officer - Revenue	West Chester, Pennsylvania, United States	Email
Dr Madhu Davies	Experienced Clinical Development	Greater Cambridge Area, United Kingdom	Email